ETIO-PATHO-MORPHOGENESIS OF COVID-19 (LITERATURE REVIEW)
Keywords:
COVID-19, SARS-CoV-2 virus, post - COVID syndrome, cardiovascular system, acute myocarditis, myocardial infarction, coronary atherosclerosiAbstract
In this review of the literature, the etio-patho-morphogenesis of the SARS-CoV-2 virus-caused COVID-19 disease - the acute stage of the disease and the manifestation of its post-disease syndromes, their effect on the cardiovascular system. The comorbidity of COVID-19 disease with other diseases of the cardiovascular system was analyzed.
References
Abdullaeva Z.A. et al. Cardiovascular complications in the background of COVID-19. CENTRAL ASIAN JOURNAL OF MEDICAL AND NATURAL SCIENCES. Volume: 03 Issue: 02 | Mar-Apr 2022. Pp. 17-21. ISSN: 2660-4159. http://cajmns. Central asian studies. Orgю (in Russ).
Barbarash O.L. et al. Novel coronavirus disease (COVID-19) and CVD. COVID-19 and cardiovascular diseases. Complex issues of CVD. DOI 10.17802/2306-1278-2020-9-2-17-28. Pp. 17-29. (in Russ).
Belyalov F.I. Treatment of internal diseases in conditions of comorbidity: monograph. – 8th ed., revised and enlarged. – Irkutsk: RIO IGMAPO, 2012. – 286 p. (in Russ).
Boytsov S.A. et al. Clinical picture and factors associated with adverse outcomes in hospitalized patients with a new coronavirus infection COVID-19. Cardiology. 2021; 61(2): 4-14. https://doi.org/ 10.18087/ cardio.2021.2.n1532 . (in Russ).
Vertkin A.L. et al. Comorbidity // Consilium Medicum Diseases of the heart and blood vessels. – 2011. – No. 2. – P. 37–41. (in Russ).
Grinevich V.B. and others. Features of managing comorbid patients during the pandemic of a new coronavirus infection (COVID-19)//Cardiovascular therapy and prevention. - 2020. - Vol. 19, No. 4. - P. 135-172. (in Russ).
Ivannikov A. A. et al. COVID-19 and the cardiovascular system. Part II. Post-COVID syndrome. Sklifosovsky Journal "Emergency Medical Care". 2021; 10 (2): 248-258. https://doi.org/10.23934/2223-9022-2021-10-2-248-25885. (in Russ).
Kirilenko N. P. et al. Mobile healthcare in the Tver region: from idea to implementation. Preventive medicine. 2019;22(3):44-50. (in Russ).
Kirilenko N.P. et al. COVID-19 and cardiovascular diseases: cardiovascular comorbidity, incidence of COVID-19, severity and post-COVID syndrome. Preventive Medicine. 2022, Vol. 25, No. 5, pp. 79-85. https://doi.org/ 10.17116/profmed 20222505179. (in Russ).
COVID-19 and the cardiovascular system. Part 1. Pathophysiology, pathomorphology, complications, long-term prognosis. Russian Sklifosovsky Journal of Emergency Medical Care. 2021;10(1):14–26. https://doi.org/ 10.23934/2223-9022-2021-10-1-14-26. (in Russ).
Chazova I.E., Mironova O.Yu. COVID-19 and cardiovascular diseases // Therapeutic archive. - 2020. - No. 9. - P. 4–7. (in Russ).
Aghagoli G., Gallo M. B., Soliman L. B. va boshqalar. COVID-19 bemorlarida yurakning ishtiroki: xavf omillari, bashorat qiluvchilar va asoratlar: ko'rib chiqish // J. Card. Surg. ‒ 2020. ‒ 19 aprel. DOI: 10.1111/joc.14538.
AmentaEM, SpalloneA, Rodriguez-BarradasMC, ElSahlyHM, AtmarRL, KulkarniPA. Postakut COVID-19: Umumiy ko'rinish va tasnifga yondashuv. Infect Dis-ni oching. 2020;7(12):ofaa509. PMID: 33403218 https://doi.org/ 10.1093/ ofid/ofaa509.
Benigni A, Cassis P, Remuzzi G. Angiotensin II qayta ko'rib chiqildi: yallig'lanish, immunologiya va qarishda yangi rollar. EMBO Mol Med. 2010;2(7):247–257. PMID: 20597104 https://doi.org/10.1002/emmm.201000080.
Basso C. va boshqalar. COVID-19 bilan bog'liq miyokard shikastlanishining patologik xususiyatlari: ko'p markazli yurak-qon tomir patologiyasini o'rganish. Eur Heart J. 2020;41(39):3827–3835. PMID: 32968776 https://doi.org/ 10.1093/eurheartj/ehaa664.
Chen C., Chjou Y., Vang D. V. SARS-CoV-2: fulminant miokarditning potentsial yangi etiologiyasi // Herz. ‒ 2020. ‒ jild. 45, № 3. ‒ B. 230‒232. DOI: 10.1007/s00059-020-04909-z.
Driggin E., Madhavan M. V., Bikdeli B. va boshqalar. COVID-19 pandemiyasi davrida bemorlar, tibbiyot xodimlari va sog'liqni saqlash tizimlari uchun yurak-qon tomir muammolari // J. Am. Koll. Kardiol. ‒ 2020. ‒ jild. 75, № 18. ‒ B. 2352‒2371. doi: 10.1016/j.jacc.2020.03.031.
Greenhalgh T, Knight M, A'Court C, Buxton M, Husain L. Birlamchi tibbiy yordamda o'tkir Covid-19 ni boshqarish. BMJ. 2020;370:m3026. PMID: 32784198 https://doi.org/10.1136/bmj.m3026.
Huang C. va boshqalar Xitoyning Uxan shahrida 2019 yilda yangi koronavirus bilan kasallangan bemorlarning klinik xususiyatlari. Lanset. 2020-yil 15-fevral;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5.
Kochi A. N., Tagliari A. P., Forleo G. B. va boshqalar. COVID-19 bilan kasallangan bemorlarda yurak va aritmik asoratlar // J. Kardiovasc. Elektrofiziol. ‒ 2020. ‒ jild. 31, № 5. ‒ B. 1003‒1008. DOI: 10.1111/jce.14479.
Li B, Yang J, Zhao F va boshqalar. Xitoyda yurak-qon tomir metabolik kasalliklarining tarqalishi va COVID-19 ga ta'siri. Clin Res Cardiol. 2020;531-538. doi: 10.1007/s00392-020-01626-9.
Li B. va boshqalar. Xitoyda yurak-qon tomir metabolik kasalliklarining COVID-19 ga tarqalishi va ta'siri. Kardiologiyada klinik tadqiqotlar.2020;109(5):531-538. https://doi.org/10.1007/s00392-020-01626-9.
Lindner D. va boshqalar. Tasdiqlangan COVID-19 otopsi holatlarida SARS-CoV-2 bilan yurak infektsiyasi assotsiatsiyasi. JAMA Kardiol. 2020;5(11):1281–1285. PMID: 32730555 https://doi.org/10.1001/jamacardio.2020.3551.
Long B. va boshqalar. COVID-19dagi yurak-qon tomir asoratlari // Am. J. Emerg. Med. ‒ 2020. ‒ 18 aprel ‒ 1‒4-bet. DOI: 10.1016/j.ajem.2020.04.048.
Ng W.H. va boshqalar. SARS-CoV-2 bilan kasallangan bemorlarda qo'shma kasalliklar: tizimli ko'rib chiqish va metaanaliz. mBio. 2021;12(1):e03647–20. PMID: 33563817 https://doi.org/10.1128/mBio.03647-20.
O'Sallivan O. Oldingi koronavirus epidemiyalaridan keyingi uzoq muddatli oqibatlar. Clin Med (Lond). 2021;21(1):e68–e70. PMID: 33144403 https://doi.org/10.7861/clinmed.2020-0204.
Sardu C. va boshqalar. Gipertenziya, tromboz, buyrak etishmovchiligi va diabet: COVID-19 endotelial kasallikmi? Klinik va asosiy dalillarni har tomonlama baholash. J Clin Med. 2020;9(5):1417. PMID: 32403217 https://doi.org/10.3390/jcm9051417.
Simmonds P, Williams S, Harvala H. COVID-19 natijalarini tushunish — oʻtkir respirator infeksiyaning joriy modeli haqiqatan ham mos keladimi? The Journal of General Virology.2021;102(3):001545. https://doi.org/10.1099/jgv.0.001545.
Soro-Paavonen A, Gordin D, Forsblom C, Rosengard-Barlund M, Waden J, Thorn L va boshqalar. 1-toifa diabet va qon tomir asoratlari bo'lgan bemorlarda aylanma ACE2 faolligi ortadi. J Gipertenziya. 2012;30(2):375–383. PMID: 22179088 https://doi.org/10.1097/hjh.0b013e32834f04b6.
Shi S., Qin M., Shen B. va boshqalar. Xitoyning Vuxan shahridagi COVID-19 bilan kasalxonaga yotqizilgan bemorlarda yurak shikastlanishining o'lim bilan assotsiatsiyasi // JAMA Cardiol. ‒ 2020. ‒ jild. 25. ‒ R. e200950. DOI: 10.1001/jamacardio.2020.0950.
Schmieder RE. Endothelial dysfunction: how can one intervene at the beginning of the cardiovascular continuum? J Hypertens Suppl. 2006;24(2):S31–35. PMID: 16601559 https://doi.org/10.1097 /01.hjh.0000220101.57896.cd.
Steyers C.M 3rd, Miller F.J. Endothelial dysfunction in chronic inflammatory diseases. Int J Mol Sci. 2014;15(7):11324–11349. PMID: 24968272 https://doi.org/10.3390/ijms150711324.
Wassmann S, Nickenig G. The role of the AT1 receptor in the cardiovascular continuum. Eur Heart J Suppl. 2004;6(Suppl_H):h3–h9. https://doi.org/10.1093/eurheartj/6.suppl_h.h3.
Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9.doi:10.1001/jama.2020.1585.
Wu Z., Mc Googan J.M. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020. Feb 24. doi: 10.1001/jama.2020.2648.
Yang J. et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. International Journal of Infectious Diseases.2020;94:91-95. https://doi.org/ 10.1016/ j.ijid.2020.03.017.
Yang C., Jin Z. An acute respiratory infection runs into the most common noncommunicable epidemic ‒ COVID-19 and Cardiovascular Diseases // JAMA Cardiol. ‒ 2020. ‒ Vol. 25. doi: 10.1001/jamacardio.2020.0934.
Yong S.J. Persistent Brainstem Dysfunction in Long-COVID: A Hypothesis. ACS Chem Neurosci. 2021;12(4):573–580. PMID: 33538586 https://doi.org/10.1021/acschemneuro.0c00793.
Zhang L, Li C, Zhou Y, Wang B, Zhang J. Persistent viral shedding lasting over 60 days in a mild COVID-19 patient with ongoing positive SARS-CoV-2. Quant Imaging Med Surg. 2020;10(5):1141–1144. PMID: 32489935 https://doi.org/10.21037/qims.2020.04.08
ZhengY.Y. et al., COVID-19 and the cardiovascular system. Nature Reviews Cardiology. 2020. Mar 5. doi: 10.1038/s41569-020-0360-5.
